Kulic, I.* ; Robertson, G.* ; Chang, L.* ; Baker, J.H.* ; Lockwood, W.W.* ; Mok, W.* ; Fuller, M.* ; Fournier, M.* ; Wong, N.* ; Chou, V.* ; Robinson, M.D.* ; Chun, H.J.* ; Gilks, B.* ; Kempkes, B. ; Thomson, T.A.* ; Hirst, M.* ; Minchinton, A.I.* ; Lam, W.L.* ; Jones, S.* ; Marra, M.* ; Karsan, A.*
Loss of the Notch effector RBPJ promotes tumorigenesis.
J. Exp. Med. 212, 37-52 (2015)
Aberrant Notch activity is oncogenic in several malignancies, but it is unclear how expression or function of downstream elements in the Notch pathway affects tumor growth. Transcriptional regulation by Notch is dependent on interaction with the DNA-binding transcriptional repressor, RBPJ, and consequent derepression or activation of associated gene promoters. We show here that RBPJ is frequently depleted in human tumors. Depletion of RBPJ in human cancer cell lines xenografted into immunodeficient mice resulted in activation of canonical Notch target genes, and accelerated tumor growth secondary to reduced cell death. Global analysis of activated regions of the genome, as defined by differential acetylation of histone H4 (H4ac), revealed that the cell death pathway was significantly dysregulated in RBPJ-depleted tumors. Analysis of transcription factor binding data identified several transcriptional activators that bind promoters with differential H4ac in RBPJ-depleted cells. Functional studies demonstrated that NF-κB and MYC were essential for survival of RBPJ-depleted cells. Thus, loss of RBPJ derepresses target gene promoters, allowing Notch-independent activation by alternate transcription factors that promote tumorigenesis.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Nf-kappa-b; Transcription Factor-binding; To-mesenchymal Transition; Cancer Genomics; Breast-cancer; C-myc; Dna; Activation; Complex; Pathway
Keywords plus
Language
english
Publication Year
2015
Prepublished in Year
2014
HGF-reported in Year
2014
ISSN (print) / ISBN
0022-1007
e-ISSN
1540-9538
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 212,
Issue: 1,
Pages: 37-52
Article Number: ,
Supplement: ,
Series
Publisher
Rockefeller University Press
Publishing Place
New York
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Immune Response and Infection
PSP Element(s)
G-501500-002
Grants
Copyright
Erfassungsdatum
2014-12-31